immunotherapy

Intellia follows CRISPR peers with deal to explore 'natural killer' cell therapy
BioPharma Dive
Tue, 02/15/22 - 11:28 pm
Intellia Therapeutics
ONK Therapeutics
natural killer cell therapy
immunotherapy
Bristol Myers returns to Immatics for a dual-targeting cancer drug
BioPharma Dive
Tue, 12/14/21 - 11:10 am
Bristol Myers Squibb
Immatics
cancer
immunotherapy
Vaxxinity, hoping to turn bodies into their own drug factories, makes a subdued Wall Street debut
Fierce Biotech
Thu, 11/11/21 - 11:03 am
Vaxxinity
IPOs
vaccines
immunotherapy
NASDAQ
Biotech Raises $140 Million to Advance iPSC-based Immunotherapies
BioSpace
Tue, 11/2/21 - 11:44 pm
Shoreline Biosciences
pluripotent stem cells
iPSC
immunotherapy
Asher Bio’s encouraging early data against rival cancer drug sparks $108M financing
MedCity News
Wed, 09/1/21 - 10:54 am
Asher Bio
funding
immunotherapy
cancer immunotherapy
Cel-Sci's 11-year cancer drug odyssey ends in failure, sinking stock, but plots FDA filing anyway
Fierce Biotech
Tue, 06/29/21 - 11:03 am
Cel-Sci
immunotherapy
clinical trials
head and neck cancer
Multikine
Guardant steps into a new arena
EP Vantage
Tue, 06/22/21 - 10:57 am
Guardant Health
liquid biopsy
immunotherapy
diagnostics
Bristol Myers details data for closely watched cancer immunotherapy
BioPharma Dive
Wed, 05/19/21 - 11:27 pm
ASCO 2021
immunotherapy
Bristol Myers Squibb
Opdivo
skin cancer
relatlimab
FDA review of Lilly/Innovent’s sintilimab paves way for cut-price immunotherapy option
Pharmaforum
Wed, 05/19/21 - 10:26 am
Eli Lilly
Innovent
China
sintilimab
Keytruda
Merck
immunotherapy
Xilio raises $95M to take twists on Yervoy and IL-2 into clinic
Fierce Biotech
Wed, 02/24/21 - 10:57 am
Xilio Therapeutics
funding
immunotherapy
clinical trials
cancer
oncology
Yervoy
Aptevo’s Phase I APVO436 Trial on Right Track Against AML
BioSpace
Tue, 11/3/20 - 09:36 pm
Aptevo
APVO436
immunotherapy
AML
clinical trials
Esmo 2020 preview – late-breaking immunotherapy
EP Vantage
Mon, 09/14/20 - 10:53 am
ESMO
immunotherapy
Big Pharma
Merck
Bristol-Meyers Squibb
cancer
Immunomedics
Roche
Corvus begins phase 1 Covid-19 clinical trial with novel immunotherapy
Pharmaceutical Business Review
Wed, 07/8/20 - 10:34 am
Corvus Pharmaceuticals
clinical trials
immunotherapy
COVID-19
CPI-006
Over a decade ago, a disastrous trial killed research on a potential immunotherapy. Can a Regeneron bispecific revive it?
Endpoints
Thu, 06/25/20 - 10:58 am
immunotherapy
Regeneron
clinical trials
bispecific antibodies
Early survival data boost Ziopharm's 'controlled IL-12' immunotherapy for glioblastoma
Endpoints
Fri, 05/29/20 - 10:52 am
Ziopharm Oncology
Ad-RTS-hIL-12
immunotherapy
glioblastoma
Roche signs up with Oncimmune to explore immunotherapy responses
Pharmaforum
Thu, 05/28/20 - 10:36 am
Roche
Oncimmune
autoantibodies
immunotherapy
Affinivax announces $120m Series B financing to advance pipeline of novel MAPS vaccines and immunotherapies
Pharmaceutical Business Review
Fri, 04/24/20 - 11:03 am
Affinivax
vaccines
MAPS
immunotherapy
BeiGene reports positive Phase III interim analysis for lung cancer drug
MedCity News
Wed, 04/15/20 - 10:41 am
BeiGene
clinical trials
immunotherapy
lung cancer
tislelizumab
non-squamous non-small cell lung cancer
Sanofi beat out 3 suitors and one last-minute bid in its pricey $2.5B Synthorx buyout
Fierce Pharma
Wed, 01/1/20 - 06:54 pm
Sanofi
Synthorx
M&A
immunotherapy
Novartis, Bayer, Longwood back genomics startup to speed search for immunotherapy targets
Endpoints
Thu, 11/21/19 - 10:21 am
Novartis
Bayer
Longwood
immunotherapy
genomics
immuno-oncology

Pages